Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
361.179026995
InChI
InChI=1S/C22H23N3O2/c26-22(20-13-17-5-1-2-6-19(17)27-20)24-21-16-7-10-25(11-8-16)18(21)12-15-4-3-9-23-14-15/h1-6,9,13-14,16,18,21H,7-8,10-12H2,(H,24,26)/t18-,21-/m0/s1
InChI Key
InChIKey=OXKRFEWMSWPKKV-RXVVDRJESA-N
IUPAC Name
N-[(2S,3S)-2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]octan-3-yl]-1-benzofuran-2-carboxamide
Traditional IUPAC Name
N-[(2S,3S)-2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]octan-3-yl]-1-benzofuran-2-carboxamide
SMILES
O=C(N[C@H]1C2CCN(CC2)[C@H]1CC1=CN=CC=C1)C1=CC2=CC=CC=C2O1
pKa (strongest acidic)
14.57
pKa (Strongest Basic)
7.44
Refractivity
103.6 m3·mol-1
Cơ Chế Tác Dụng :
TC-5619, a novel small molecule that modulates the activity of the neuronal nicotinic receptor (NNR) subtype known as alpha7(α7). TC-5619 belongs to a new class of drugs for the treatment of central nervous system diseases and disorders.
TC-5619, a novel small molecule that modulates the activity of the neuronal nicotinic receptor (NNR) subtype known as alpha7(α7). The α7 NNR is associated with a variety of biological functions. In particular, the α7 NNR has been shown in animal studies to be an essential regulator of both inflammation arising from injury or infection and cognitive functions. α7 NNR plays a role in protecting neuronal cells from deterioration and death, a process known as neuroprotection.
Chỉ Định :
Investigated for use/treatment in neurologic disorders.